226 related articles for article (PubMed ID: 26723887)
1. Cell-based assays to support the profiling of small molecules with histone methyltransferase and demethylase modulatory activity.
Martinez NJ; Simeonov A
Drug Discov Today Technol; 2015 Nov; 18():9-17. PubMed ID: 26723887
[TBL] [Abstract][Full Text] [Related]
2. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-based methods for screening writers and readers of histone methyl marks.
Allali-Hassani A; Wasney GA; Siarheyeva A; Hajian T; Arrowsmith CH; Vedadi M
J Biomol Screen; 2012 Jan; 17(1):71-84. PubMed ID: 21972038
[TBL] [Abstract][Full Text] [Related]
4. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
Wang Z; Patel DJ
Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
[TBL] [Abstract][Full Text] [Related]
7. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
8. Co-regulation of histone-modifying enzymes in cancer.
Islam AB; Richter WF; Jacobs LA; Lopez-Bigas N; Benevolenskaya EV
PLoS One; 2011; 6(8):e24023. PubMed ID: 21886846
[TBL] [Abstract][Full Text] [Related]
9. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
[TBL] [Abstract][Full Text] [Related]
10. Targeting histone lysine methylation in cancer.
McGrath J; Trojer P
Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
[TBL] [Abstract][Full Text] [Related]
11. Screening assays for epigenetic targets using native histones as substrates.
Hauser AT; Bissinger EM; Metzger E; Repenning A; Bauer UM; Mai A; Schüle R; Jung M
J Biomol Screen; 2012 Jan; 17(1):18-26. PubMed ID: 21965113
[TBL] [Abstract][Full Text] [Related]
12. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
[TBL] [Abstract][Full Text] [Related]
14. Assessing histone demethylase inhibitors in cells: lessons learned.
Hatch SB; Yapp C; Montenegro RC; Savitsky P; Gamble V; Tumber A; Ruda GF; Bavetsias V; Fedorov O; Atrash B; Raynaud F; Lanigan R; Carmichael L; Tomlin K; Burke R; Westaway SM; Brown JA; Prinjha RK; Martinez ED; Oppermann U; Schofield CJ; Bountra C; Kawamura A; Blagg J; Brennan PE; Rossanese O; Müller S
Epigenetics Chromatin; 2017; 10():9. PubMed ID: 28265301
[TBL] [Abstract][Full Text] [Related]
15. Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis.
Wigle TJ; Provencher LM; Norris JL; Jin J; Brown PJ; Frye SV; Janzen WP
Chem Biol; 2010 Jul; 17(7):695-704. PubMed ID: 20659682
[TBL] [Abstract][Full Text] [Related]
16. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
17. The future therapeutic potential of histone demethylases: A critical analysis.
Natoli G; Testa G; De Santa F
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
[TBL] [Abstract][Full Text] [Related]
18. Interaction between DNA/histone methyltransferases and their inhibitors.
Hu J; Chen S; Kong X; Zhu K; Cheng S; Zheng M; Jiang H; Luo C
Curr Med Chem; 2015; 22(3):360-72. PubMed ID: 25386815
[TBL] [Abstract][Full Text] [Related]
19. Chemical and biochemical approaches in the study of histone methylation and demethylation.
Li KK; Luo C; Wang D; Jiang H; Zheng YG
Med Res Rev; 2012 Jul; 32(4):815-67. PubMed ID: 22777714
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on histone demethylases.
Tian X; Fang J
Acta Biochim Biophys Sin (Shanghai); 2007 Feb; 39(2):81-8. PubMed ID: 17277881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
